Cancer Proteomics Tumor Analysis Consortium Prospective Biospecimen Collection Protocol, Breast Cancer
BRD ID: 301
Source: CPTAC Tier: SOP Number of times downloaded: 2455
Description
This document describes three options for the procurement of ductal and lobular breast cancer specimens, stage IIA-IIIC, to be used for proteomics or genomic analysis. The three tissue procurement procedures described are (i) tumor excision at lumpectomy/mastectomy, (ii) large-bore percutaneous tumor coring before lumpectomy/mastectomy, and (iii) large-bore percutaneous coring during port placement. Specimens are suitable for genomic or proteomic analysis. A procedure for the collection of peripheral venous blood prior to the administration of anesthesia is also included. Protocols are a product of the Clinical Proteomic Tumor Analysis Consortium (CPTAC; http://proteomics.cancer.gov/programs/cptacnetwork), which is sponsored by the National Cancer Institute's Office of Cancer Clinical Proteomics Research (http://proteomics.cancer.gov/).
Documents for Download
CPTAC_Breast_Procurement_Protocol_v1_9.pdf [Size: 228 KB]Biospecimens
- Tissue - Breast
- Fluid - Blood
- Fluid - Plasma
Diagnoses
- Neoplastic - Carcinoma
- Neoplastic - Normal Adjacent
Topics
- Biospecimen Acquisition
- Biospecimen Preservation
Associated SOP Compendiums
- Biospecimen Acquisition
- Biospecimen Preservation